{"id":349,"date":"2022-12-27T23:48:36","date_gmt":"2022-12-27T22:48:36","guid":{"rendered":"https:\/\/antikoncepcia.org\/?p=349"},"modified":"2022-12-28T15:07:48","modified_gmt":"2022-12-28T14:07:48","slug":"kozne-ochorenia-a-esteticke-problemy-sposobene-hak","status":"publish","type":"post","link":"https:\/\/antikoncepcia.org\/?p=349","title":{"rendered":"Ko\u017en\u00e9 ochorenia a estetick\u00e9 probl\u00e9my sp\u00f4soben\u00e9 HAK"},"content":{"rendered":"<p>V\u0161eobecne je preferovan\u00e9 tvrdenie, \u017ee hormon\u00e1lna antikoncepcia m\u00e1 pozit\u00edvny vplyv na poko\u017eku \u017eien, najm\u00e4 v\u00a0pr\u00edpadoch zv\u00fd\u0161enej produkcie androg\u00e9nov (skupina horm\u00f3nov, ktor\u00e9 prim\u00e1rne ovplyv\u0148uj\u00fa rast a v\u00fdvin mu\u017esk\u00e9ho reproduk\u010dn\u00e9ho syst\u00e9mu).<a href=\"#_edn1\" name=\"_ednref1\">[i]<\/a> Pr\u00ed\u010dinou akn\u00e9 v\u0161ak nemusia by\u0165 len androg\u00e9ny. V\u00fdznamn\u00fa \u00falohu zohr\u00e1vaj\u00fa aj in\u00e9 faktory, napr. genetick\u00e1 predispoz\u00edcia, preinflama\u010dn\u00e9 lipidy, mechanizmy neuroendokrinnej regul\u00e1cie, di\u00e9ta a viacer\u00e9 vonkaj\u0161ie faktory.<a href=\"#_edn2\" name=\"_ednref2\">[ii]<\/a> U\u00a0dospievaj\u00facich diev\u010dat pr\u00ed\u010dinou akn\u00e9 nemusia by\u0165 zv\u00fd\u0161en\u00e9 koncentr\u00e1cie androg\u00e9nov, ale len do\u010dasne nadmerne zv\u00fd\u0161en\u00e1 citlivos\u0165 mazov\u00fdch \u017eliaz vo\u010di ich pr\u00edtomnosti, ke\u010f\u017ee androg\u00e9ny boli po\u010das detsk\u00e9ho obdobia produkovan\u00e9 len v mal\u00fdch mno\u017estv\u00e1ch.<a href=\"#_edn3\" name=\"_ednref3\">[iii]<\/a><\/p>\n<p>Najz\u00e1va\u017enej\u0161\u00edm ochoren\u00edm ko\u017ee s\u00favisiacim s\u00a0u\u017e\u00edvan\u00edm hormon\u00e1lnej antikoncepcie je <strong>rakovina ko\u017ee<\/strong>. Viacer\u00e9 \u0161t\u00fadie zistili v\u00fdznamne zv\u00fd\u0161en\u00fd v\u00fdskyt rakoviny ko\u017ee (skvamocelul\u00e1rny, bazocelul\u00e1rny karcin\u00f3m) u\u00a0u\u017e\u00edvateliek hormon\u00e1lnej antikoncepcie (<em>Oshyvalova a\u00a0kol., 2019<\/em><a href=\"#_edn4\" name=\"_ednref4\">[iv]<\/a>, <em>Kuklinski a kol., 2016<\/em><a href=\"#_edn5\" name=\"_ednref5\">[v]<\/a>, <em>Beheshtiroy a\u00a0kol., 2014<\/em><a href=\"#_edn6\" name=\"_ednref6\">[vi]<\/a>) vr\u00e1tane <strong>melan\u00f3mu<\/strong> (<em>Sun a\u00a0kol., 2020<\/em><a href=\"#_edn7\" name=\"_ednref7\">[vii]<\/a>, <em>European prospective investigation into cancer and nutrition,<\/em><em> 2020<\/em><a href=\"#_edn8\" name=\"_ednref8\">[viii]<\/a>, <em>Cervenka a\u00a0kol., 2018<\/em><a href=\"#_edn9\" name=\"_ednref9\">[ix]<\/a>). Vo ve\u013ekej meta-anal\u00fdze, ktor\u00fa vykonali <em>Sun a\u00a0kol.<\/em> (2020) riziko melan\u00f3mu r\u00e1stlo s\u00a0d\u013a\u017ekou u\u017e\u00edvania peror\u00e1lnej antikoncepcie; pri jej u\u017e\u00edvan\u00ed 5 rokov a\u00a0dlh\u0161ie bolo riziko zv\u00fd\u0161en\u00e9 o\u00a018% (RR 1.18; 95%CI: 1.07\u20131.31) a\u00a0pri u\u017e\u00edvan\u00ed 10 rokov a\u00a0dlh\u0161ie o\u00a025% (RR 1.25; 95%CI: 1.06\u20131.48). V\u00fdznamn\u00e9, o\u00a052% zv\u00fd\u0161en\u00e9 riziko melan\u00f3mu bolo zisten\u00e9 u\u00a0\u017eien, u ktor\u00fdch od prv\u00e9ho u\u017eitia peror\u00e1lnej antikoncepcie uplynulo 15 \u2013 19 rokov (RR 1.52, 95%CI: 1,03\u20132,24).<a href=\"#_edn10\" name=\"_ednref10\">[x]<\/a><\/p>\n<p><strong>Syst\u00e9mov\u00fd lupus erythematosus<\/strong> je \u010fal\u0161ie v\u00e1\u017ene ochorenie, ktor\u00e9 m\u00f4\u017ee by\u0165 sp\u00f4soben\u00e9 u\u017e\u00edvan\u00edm hormon\u00e1lnej antikoncepcie. Jedn\u00e1 sa o autoimunitn\u00e9 ochorenie, pri ktorom imunitn\u00fd syst\u00e9m nap\u00e1da vlastn\u00e9 tkaniv\u00e1 a sp\u00f4sobuje rozsiahly z\u00e1pal a po\u0161kodenie tkan\u00edv v postihnut\u00fdch org\u00e1noch.<a href=\"#_edn11\" name=\"_ednref11\">[xi]<\/a> Vo ve\u013ekej \u0161t\u00fadii zah\u0155\u0148aj\u00facej 238 308 \u017eien (<em>Costenbader a\u00a0kol., 2007<\/em>), u\u017e\u00edvanie peror\u00e1lnej antikoncepcie v\u00fdznamne zv\u00fd\u0161ilo riziko syst\u00e9mov\u00e9ho lupus erythematosus (RR 1.5, 95%CI: 1.1\u22122.1).<a href=\"#_edn12\" name=\"_ednref12\">[xii]<\/a> Podobne aj \u010fal\u0161ie \u0161t\u00fadie hl\u00e1sili zv\u00fd\u0161en\u00fd v\u00fdskyt tohto ochorenia u u\u017e\u00edvateliek peror\u00e1lnej antikoncepcie (<em>Bernier a\u00a0kol.,2009<\/em><a href=\"#_edn13\" name=\"_ednref13\">[xiii]<\/a>, <em>Sanchez-Guerrero a kol., 1997<\/em><a href=\"#_edn14\" name=\"_ednref14\">[xiv]<\/a>).<\/p>\n<p>Prepar\u00e1ty obsahuj\u00face syntetick\u00e9 gestag\u00e9ny s <strong>androg\u00e9nnym<\/strong> \u00fa\u010dinkom (napr. levonorgestrel, noretister\u00f3n, norgestim\u00e1t, desogestrel, gestod\u00e9n) m\u00f4\u017eu sp\u00f4sobi\u0165 <strong>akn\u00e9 a\u00a0zv\u00fd\u0161en\u00fa tvorbu mazu (sebarrhoea)<\/strong>. Nepr\u00edjemn\u00fdm estetick\u00fdm ochoren\u00edm je <strong>dif\u00fazne vypad\u00e1vanie vlasov tzv. effl\u00favium<\/strong>, ktor\u00e9 sa pripisuje najm\u00e4 p\u00f4sobeniu syntetick\u00fdch gestag\u00e9nov obsiahnut\u00fdch v\u00a0hormon\u00e1lnej antikoncepcii (<em>Tosti a\u00a0kol., 2009<\/em><a href=\"#_edn15\" name=\"_ednref15\">[xv]<\/a>, <em>Leidenberger a\u00a0kol., 2009<\/em><a href=\"#_edn16\" name=\"_ednref16\">[xvi]<\/a>).<\/p>\n<p>\u010eal\u0161\u00edm ko\u017en\u00fdm ne\u017eiaducim \u00fa\u010dinkom peror\u00e1lnej antikoncepcie je <strong>chloazma (melasma)<\/strong>, ktor\u00e1 sa prejavuje zv\u00fd\u0161enou pigment\u00e1ciou poko\u017eky v\u00a0d\u00f4sledku zv\u00fd\u0161en\u00e9ho ukladania melan\u00ednu. Ochorenie sa vyskytuje pribli\u017ene u\u00a010 \u2013 20% u\u017e\u00edvateliek kombinovanej peror\u00e1lnej antikoncepcie (<em>Pol\u00e1kov\u00e1, 2010<\/em><a href=\"#_edn17\" name=\"_ednref17\">[xvii]<\/a>). Podobne aj \u010fal\u0161ie v\u00fdskumy zistili zv\u00fd\u0161en\u00fd v\u00fdskyt chloazmy u\u00a0u\u017e\u00edvateliek hormon\u00e1lnej antikoncepcie (<em>Sheth a\u00a0kol., 2011<\/em><a href=\"#_edn18\" name=\"_ednref18\">[xviii]<\/a>, <em>Ortonne a kol., 2009<\/em><a href=\"#_edn19\" name=\"_ednref19\">[xix]<\/a>).<\/p>\n<p>Estetick\u00e9 probl\u00e9my sp\u00f4soben\u00e9 u\u017e\u00edvan\u00edm hormon\u00e1lnej antikoncepcie m\u00f4\u017eu by\u0165 sp\u00f4soben\u00e9 aj jej negat\u00edvnym vplyvom na cievy. Prejavuj\u00fa sa <strong>roz\u0161\u00edren\u00edm mal\u00fdch alebo koncov\u00fdch ciev<\/strong> <strong>(telangiekt\u00e1zia)<\/strong>, <strong>angi\u00f3mami (nezhubn\u00e9 n\u00e1dory ciev)<\/strong> alebo ako <strong>livedo reticularis\/<\/strong> <strong>livedo racemosa <\/strong>(sie\u0165ovit\u00e9, \u0161kvrnit\u00e9, ostro ohrani\u010den\u00e9 alebo prel\u00ednaj\u00face sa modrast\u00e9 zafarbenie v\u00a0 ko\u017ei).<a href=\"#_edn20\" name=\"_ednref20\">[xx]<\/a> Na riziko v\u00fdvinu t\u00fdchto ochoren\u00ed u\u00a0\u017eien pou\u017e\u00edvaj\u00facich hormon\u00e1lnu antikoncepciu upozornili viacer\u00ed autori (<em>El-Darouti, 2019<\/em><a href=\"#_edn21\" name=\"_ednref21\">[xxi]<\/a>, <em>Leidenberger a\u00a0kol., 2009<\/em><a href=\"#_edn22\" name=\"_ednref22\">[xxii]<\/a>, <em>Deharo a kol., 1988<\/em><a href=\"#_edn23\" name=\"_ednref23\">[xxiii]<\/a>, <em>Asherson a\u00a0kol., 1988<\/em><a href=\"#_edn24\" name=\"_ednref24\">[xxiv]<\/a>).<\/p>\n<p><strong>Erythema nodosum <\/strong>\u2013 toto ochorenie sp\u00f4sobuje bolestiv\u00e9 symetrick\u00e9 podko\u017en\u00e9 uzliny, \u010dasto s priemerom 1 \u2013 6 cm, v oblasti tv\u00e1re a krku, naj\u010dastej\u0161ie sa v\u0161ak vyskytuj\u00fa na prednej \u010dasti doln\u00fdch kon\u010dat\u00edn.<a href=\"#_edn25\" name=\"_ednref25\">[xxv]<\/a> Zv\u00fd\u0161en\u00fd v\u00fdskyt erythema nodosum u\u00a0\u017eien, ktor\u00e9 u\u017e\u00edvali peror\u00e1lnu hormon\u00e1lnu antikoncepciu pozorovali viacer\u00e9 \u0161t\u00fadie (<em>Molina-Ruiz a\u00a0kol., 2016<\/em><a href=\"#_edn26\" name=\"_ednref26\">[xxvi]<\/a>, <em>Borroni a kol., 2014<\/em><a href=\"#_edn27\" name=\"_ednref27\">[xxvii]<\/a>).<\/p>\n<p>Hormon\u00e1lna antikoncepcia m\u00f4\u017ee vies\u0165 aj k v\u00fdvinu <strong>ekz\u00e9mov <\/strong>a<strong>\u00a0dermatit\u00eddy<\/strong> (z\u00e1palov\u00e9 ochorenie ko\u017ee). Vo ve\u013ekej multicentrickej \u0161t\u00fadii (<em>Vessey a\u00a0kol., 2000<\/em>), u\u017e\u00edvanie peror\u00e1lnej antikoncepcie zv\u00fd\u0161ilo riziko t\u00fdchto ochoren\u00ed o\u00a060% (RR 1.6, 95%Cl: 1.2\u22122.1).<a href=\"#_edn28\" name=\"_ednref28\">[xxviii]<\/a><\/p>\n<p>Niektor\u00e9 typy hormon\u00e1lnej antikoncepcie (peror\u00e1lne formy obsahuj\u00face gestag\u00e9n s\u00a0antiandrog\u00e9nnym \u00fa\u010dinkom) m\u00f4\u017eu zlep\u0161i\u0165 prejavy akn\u00e9, ak s\u00fa sp\u00f4soben\u00e9 nadmernou produkciou androg\u00e9nov, <strong>ale na druhej strane jej pou\u017e\u00edvanie m\u00f4\u017ee sp\u00f4sobi\u0165 cel\u00fd rad v\u00e1\u017enych ko\u017en\u00fdch ochoren\u00ed, vr\u00e1tane<\/strong> <strong>onkologick\u00fdch.<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>Odborn\u00e9 pramene<\/strong><\/em><\/p>\n<p><a href=\"#_ednref1\" name=\"_edn1\">[i]<\/a> Encyclopaedia Britannica. Androgen. <a href=\"https:\/\/www.britannica.com\/science\/androgen\">https:\/\/www.britannica.com\/science\/androgen<\/a>. Accessed 2 Feb 2021.<\/p>\n<p><a href=\"#_ednref2\" name=\"_edn2\">[ii]<\/a> <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Gollnick%20HP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24828100\">G<\/a>ollnick HP, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Zouboulis%20CC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24828100\">Zouboulis<\/a> CC. Not all acne is acne vulgaris. Deutsches \u00c4rzteblatt International. 2014 Apr 25;111(17):301-12.<\/p>\n<p><a href=\"#_ednref3\" name=\"_edn3\">[iii]<\/a> Leidenberger F, Strowitzki T, Ortmann O. Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte, 4th ed. Heidelberg: Springer Medizin Verlag, 2009.<\/p>\n<p><a href=\"#_ednref4\" name=\"_edn4\">[iv]<\/a> \u041eshyvalova \u041e\u041e, Ziukov OL, Gurianov VG. Prognostic model of skin cancer risk assessment. Wiadomos\u0301ci Lekarskie. 2019;72(5 cz 1):817-822.<\/p>\n<p><a href=\"#_ednref5\" name=\"_edn5\">[v]<\/a> Kuklinski LF, Zens MS, Perry AE, et al. Sex hormones and the risk of keratinocyte cancers among women in the United States: a population-based case-control study. International Journal of Cancer. 2016 Jul;139(2):300-309.<\/p>\n<p><a href=\"#_ednref6\" name=\"_edn6\">[vi]<\/a> Beheshtiroy A. Hajmanoochehri F. Epidemiological Study of Non-Melanoma Skin Cancers Qazvin Province, Iran. Biotechnology and Health Sciences. 2014 November; 1(3): e25362.<\/p>\n<p><a href=\"#_ednref7\" name=\"_edn7\">[vii]<\/a> Sun Q, Sun H, Cong L, Zheng Y, et al. Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis. Clinical Epidemiology. 2020;12:1183-1203.<\/p>\n<p><a href=\"#_ednref8\" name=\"_edn8\">[viii]<\/a> Cervenka I, Al Rahmoun M, Mahamat-Saleh Y, et al. Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer. 2020 Jun 15;146(12):3267-3280.<\/p>\n<p><a href=\"#_ednref9\" name=\"_edn9\">[ix]<\/a> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Cervenka%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29978471\">Cervenka I<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Mahamat-Saleh%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29978471\">Mahamat-Saleh Y<\/a>, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Savoye%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29978471\">Savoye I<\/a>, et al. Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study. International Journal of Cancer. 2018 Nov 15;143(10):2390-2399<\/p>\n<p><a href=\"#_ednref10\" name=\"_edn10\">[x]<\/a> Sun Q, Sun H, Cong L, Zheng Y, et al. Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis. Clinical epidemiology. 2020;12:1183-1203.<\/p>\n<p><a href=\"#_ednref11\" name=\"_edn11\">[xi]<\/a> Centers for Disease Control and Prevention. Systemic Lupus Erythematosus. <a href=\"https:\/\/www.cdc.gov\/lupus\/facts\/detailed.html\">https:\/\/www.cdc.gov\/lupus\/facts\/detailed.html<\/a>. Accessed 2 December 2020.<\/p>\n<p><a href=\"#_ednref12\" name=\"_edn12\">[xii]<\/a> Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis and Rheumatism. 2007 Apr;56(4):1251-62. .<\/p>\n<p><a href=\"#_ednref13\" name=\"_edn13\">[xiii]<\/a> Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis and Rheumatism.\u00a0 2009 Apr 15;61(4):476-81.<\/p>\n<p><a href=\"#_ednref14\" name=\"_edn14\">[xiv]<\/a> Sanchez-Guerrero J, Karlson EW, Liang MH, et al. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis and Rheumatism. 1997 May;40(5):804-8.<\/p>\n<p><a href=\"#_ednref15\" name=\"_edn15\">[xv]<\/a> Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatologic Clinics. 2007 Apr;25(2):223-31, vii.<\/p>\n<p><a href=\"#_ednref16\" name=\"_edn16\">[xvi]<\/a> Leidenberger F, Strowitzki T, Ortmann O. Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte, 4th ed. Heidelberg: Springer Medizin Verlag, 2009. s. 278.<\/p>\n<p><a href=\"#_ednref17\" name=\"_edn17\">[xvii]<\/a> Polakova\u00a0 K. Spolupr\u00e1ca gynekol\u00f3ga a\u00a0dermatol\u00f3ga pri u\u017e\u00edvan\u00ed kombinovanej hormon\u00e1lnej antikoncepcie s antiandrog\u00e9nov\u00fdm \u00fa\u010dinkom. Dermatol\u00f3gia pre Prax. 2010, 4(3): 113\u2013115.<\/p>\n<p><a href=\"#_ednref18\" name=\"_edn18\">[xviii]<\/a> Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. \u00a0Journal of the American Academy of Dermatology. 2011 Oct;65(4):689-697.<\/p>\n<p><a href=\"#_ednref19\" name=\"_edn19\">[xix]<\/a> Ortonne JP, Arellano I, Berneburg M, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. Journal of the European Academy of Dermatology and Venereology : JEADV. 2009 Nov;23(11):1254-62.<\/p>\n<p><a href=\"#_ednref20\" name=\"_edn20\">[xx]<\/a> Leidenberger F, Strowitzki T, Ortmann O. Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte, 4th ed. Heidelberg: Springer Medizin Verlag, 2009. s .278.<\/p>\n<p><a href=\"#_ednref21\" name=\"_edn21\">[xxi]<\/a> El-Darouti MA., Al-Ali FM. Livedo Reticularis Associated with Ulceration. In: Challenging Cases in Dermatology Volume 2. Springer, Cham. 2019. https:\/\/doi.org\/10.1007\/978-3-030-21855-3_9.<\/p>\n<p><a href=\"#_ednref22\" name=\"_edn22\">[xxii]<\/a> Leidenberger F, Strowitzki T, Ortmann O. Klinische Endokrinologie f\u00fcr Frauen\u00e4rzte, 4th ed. Heidelberg: Springer Medizin Verlag, 2009. s. 278.<\/p>\n<p><a href=\"#_ednref23\" name=\"_edn23\">[xxiii]<\/a> Deharo C, Berbis P, Privat Y. Complications dermatologiques des contraceptifs oraux [Dermatological complications caused by oral contraceptives]. Fertilite\u0301, Contraception, Sexualite\u0301.\u00a0 1988 Apr;16(4):299-304.<\/p>\n<p><a href=\"#_ednref24\" name=\"_edn24\">[xxiv]<\/a> Asherson RA, Harris EN, Hughes GR, Farquharson RG. Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al. Arthritis and Rheumatism. 1988 Apr;31(4):575-6.<\/p>\n<p><a href=\"#_ednref25\" name=\"_edn25\">[xxv]<\/a> Andrews C, Mathew J. The morning after rash: Erythema nodosum due to emergency contraception. Journal of Case Reports and Images in Medicine.\u00a0 2018;4:100045Z09CA2018.<\/p>\n<p><a href=\"#_ednref26\" name=\"_edn26\">[xxvi]<\/a> Molina-Ruiz\u00a0 AM,\u00a0 Requena L.\u00a0 Erythema nodosum. Medicina Cl\u00ednica (English Edition), 2016; 147(2): 81\u201386.<\/p>\n<p><a href=\"#_ednref27\" name=\"_edn27\">[xxvii]<\/a> Borroni G, Torti S, D&#8217;Ospina RM, Pezzini C. Drug-induced panniculitides. Giornale Italiano di Dermatologia e Venereologia : Organo Ufficiale, Societa\u0300 Italiana di Dermatologia e Sifilografia. 2014 Apr;149(2):263-70.<\/p>\n<p><a href=\"#_ednref28\" name=\"_edn28\">[xxviii]<\/a> Vessey MP, Painter R, Powell J. Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index. Findings in a large cohort study. The British Journal of Dermatology.2000 Oct;143(4):815-20.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>V\u0161eobecne je preferovan\u00e9 tvrdenie, \u017ee hormon\u00e1lna antikoncepcia m\u00e1 pozit\u00edvny vplyv &hellip; <\/p>\n","protected":false},"author":4,"featured_media":356,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[155,67,2,57],"tags":[68,60,243,71,248,239,73,247,246,240,72,245,237,241,244,75,236,70,238,242,249],"class_list":["post-349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clanky","category-krasa","category-rakovina","category-zdravie","tag-akne","tag-androgeny","tag-angiomy","tag-chloazma","tag-dermatitidy","tag-difuzne-vypadavanie-vlasov","tag-effluvium","tag-ekzemy","tag-erythema-nodosum","tag-gestageny","tag-livedo-racemosa","tag-livedo-reticularis","tag-melanom","tag-melasma","tag-nezhubne-nadory-ciev","tag-pokozka","tag-rakovina-koze","tag-sebarrhoea","tag-systemovy-lupus-erythematosus","tag-telangiektazia","tag-zapalove-ochorenie-koze"],"_links":{"self":[{"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/posts\/349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=349"}],"version-history":[{"count":5,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/posts\/349\/revisions"}],"predecessor-version":[{"id":386,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/posts\/349\/revisions\/386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=\/wp\/v2\/media\/356"}],"wp:attachment":[{"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/antikoncepcia.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}